Vectors Research Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,000
| Closed | -$12K | – | 140 |
|
|
2022
Q2 | $12K | Buy |
+7,000
| New | +$12K | ﹤0.01% | 329 |
|
|
2022
Q1 | – | Sell |
-7,000
| Closed | -$26K | – | 463 |
|
|
2021
Q4 | $26K | Buy |
7,000
+1,000
| +17% | +$3.71K | 0.01% | 311 |
|
|
2021
Q3 | $31K | Buy |
6,000
+2,000
| +50% | +$10.3K | 0.01% | 271 |
|
|
2021
Q2 | $17K | Buy |
+4,000
| New | +$17K | ﹤0.01% | 324 |
|